Medicilon Reviews

2.9

44% would recommend to a friend

(7 total reviews)
avatar

Chunlin Chen

27% approve of CEO

20% positive business outlook

Reviews by job title

7 reviews
1.0
23 Sept 2024
Recommend
CEO approval
Business outlook

Pros

Interesting science remote work large budget

Cons

constant in fighting abysmal communication failed projects including falsified data stealing territory racism horrible commission structure extremely high turnover (average 3-4 months per employee)

1.0
3 Feb 2023
Recommend
CEO approval
Business outlook

Pros

None to share at all

Cons

Extremely poor management Very shady organization (when China was under a complete lockdown, the CEO flew to the US from China! How was that allowed?) Poor or zero communication from parent company in China. Unreal expectations of business possibilities.

3.0
14 Sept 2025

Expanding Team with Room for Development

Anonymous employee
Recommend
CEO approval
Business outlook

Pros

Growing company with opportunities to take on leadership roles as the team expands. Broad exposure across operations, procurement, and support for the science team

Cons

Processes and structures are still developing, which can create ambiguity. Limited resources compared to larger biotech companies.

Viewing 1 - 3 of 7 Reviews

Glassdoor has 7 Medicilon reviews submitted anonymously by Medicilon employees. Read employee reviews and ratings on Glassdoor to decide if Medicilon is right for you.